213 related articles for article (PubMed ID: 20582308)
1. Structural optimization and de novo design of dengue virus entry inhibitory peptides.
Costin JM; Jenwitheesuk E; Lok SM; Hunsperger E; Conrads KA; Fontaine KA; Rees CR; Rossmann MG; Isern S; Samudrala R; Michael SF
PLoS Negl Trop Dis; 2010 Jun; 4(6):e721. PubMed ID: 20582308
[TBL] [Abstract][Full Text] [Related]
2. Peptide inhibitors of dengue virus and West Nile virus infectivity.
Hrobowski YM; Garry RF; Michael SF
Virol J; 2005 Jun; 2():49. PubMed ID: 15927084
[TBL] [Abstract][Full Text] [Related]
3. Computational identification of self-inhibitory peptides from envelope proteins.
Xu Y; Rahman NA; Othman R; Hu P; Huang M
Proteins; 2012 Aug; 80(9):2154-68. PubMed ID: 22544824
[TBL] [Abstract][Full Text] [Related]
4. In vitro analysis of synthetic peptides in blocking the entry of dengue virus.
John AM; Jittmittraphap A; Chattanadee S; Alwin Prem Anand A; Shenbagarathai R; Leaungwutiwong P
Virus Res; 2019 Jan; 260():142-150. PubMed ID: 30508603
[TBL] [Abstract][Full Text] [Related]
5. Peptide inhibitors against dengue virus infection.
Panya A; Bangphoomi K; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2014 Aug; 84(2):148-57. PubMed ID: 24612829
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule inhibitors of dengue-virus entry.
Schmidt AG; Lee K; Yang PL; Harrison SC
PLoS Pathog; 2012; 8(4):e1002627. PubMed ID: 22496653
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of dengue virus entry into target cells using synthetic antiviral peptides.
Alhoot MA; Rathinam AK; Wang SM; Manikam R; Sekaran SD
Int J Med Sci; 2013; 10(6):719-29. PubMed ID: 23630436
[TBL] [Abstract][Full Text] [Related]
8. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection.
Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT
Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143
[TBL] [Abstract][Full Text] [Related]
9. Peptides P4 and P7 derived from E protein inhibit entry of dengue virus serotype 2 via interacting with β3 integrin.
Cui X; Wu Y; Fan D; Gao N; Ming Y; Wang P; An J
Antiviral Res; 2018 Jul; 155():20-27. PubMed ID: 29709564
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Immunologically Inspired Small Molecules That Target the Viral Envelope Protein.
Lian W; Jang J; Potisopon S; Li PC; Rahmeh A; Wang J; Kwiatkowski NP; Gray NS; Yang PL
ACS Infect Dis; 2018 Sep; 4(9):1395-1406. PubMed ID: 30027735
[TBL] [Abstract][Full Text] [Related]
11. Peptide inhibitors of dengue-virus entry target a late-stage fusion intermediate.
Schmidt AG; Yang PL; Harrison SC
PLoS Pathog; 2010 Apr; 6(4):e1000851. PubMed ID: 20386713
[TBL] [Abstract][Full Text] [Related]
12. Viral entry inhibitors block dengue antibody-dependent enhancement in vitro.
Nicholson CO; Costin JM; Rowe DK; Lin L; Jenwitheesuk E; Samudrala R; Isern S; Michael SF
Antiviral Res; 2011 Jan; 89(1):71-4. PubMed ID: 21093488
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate-related inhibitors of dengue virus entry.
Hidari KI; Abe T; Suzuki T
Viruses; 2013 Feb; 5(2):605-18. PubMed ID: 23389466
[TBL] [Abstract][Full Text] [Related]
14. Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement.
Hughes HR; Crill WD; Chang GJ
Virol J; 2012 Jun; 9():115. PubMed ID: 22709350
[TBL] [Abstract][Full Text] [Related]
15. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
[TBL] [Abstract][Full Text] [Related]
16. Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III.
Zu X; Liu Y; Wang S; Jin R; Zhou Z; Liu H; Gong R; Xiao G; Wang W
Antiviral Res; 2014 Apr; 104():7-14. PubMed ID: 24468276
[TBL] [Abstract][Full Text] [Related]
17. Progress in the identification of dengue virus entry/fusion inhibitors.
De La Guardia C; Lleonart R
Biomed Res Int; 2014; 2014():825039. PubMed ID: 25157370
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of antiviral potency of paramyxovirus entry inhibitors.
Porotto M; Carta P; Deng Y; Kellogg GE; Whitt M; Lu M; Mungall BA; Moscona A
J Virol; 2007 Oct; 81(19):10567-74. PubMed ID: 17652384
[TBL] [Abstract][Full Text] [Related]
19. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT
Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425
[TBL] [Abstract][Full Text] [Related]
20. The stem region of premembrane protein plays an important role in the virus surface protein rearrangement during dengue maturation.
Zhang Q; Hunke C; Yau YH; Seow V; Lee S; Tanner LB; Guan XL; Wenk MR; Fibriansah G; Chew PL; Kukkaro P; Biukovic G; Shi PY; Shochat SG; Grüber G; Lok SM
J Biol Chem; 2012 Nov; 287(48):40525-34. PubMed ID: 23035113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]